Nov 6, 2018
The outbreak of Ebola virus disease in the Democratic Republic of the Congo has become so serious that international public health experts should consider that it may not be able to be brought under control and it could become entrenched.
Jun 26, 2020
The Centers for Disease Control and Prevention joined the World Health Organization to declare the end of the Ebola Virus Disease outbreak in the Democratic Republic of the Congo.
Dec 20, 2019
The Food and Drug Administration yesterday approved the first FDA-approved vaccine to prevent Ebola in adults with Zaire ebolavirus, which killed more than 10,000 people during a 2014-2016 outbreak in West Africa.
Oct 14, 2019
The Food and Drug Administration last week authorized marketing of a rapid diagnostic test to detect Ebola virus antigens in human blood from certain living individuals as well as samples from those recently deceased who are suspected to have died from Ebola.
Oct 2, 2019
The Department of Health and Human Services yesterday awarded $20.5 million to develop vaccine candidates for Marburg virus and Sudan ebolavirus, which are in the same family of viruses as the Ebola virus outbreak in the Democratic Republic of the Congo.
Sep 23, 2019
The World Health Organization recently deployed a rapid response team and personal protective equipment to the United Republic of Tanzania following unofficial reports of two suspected cases of Ebola virus disease in the African nation.
Sep 6, 2019
One year after the Democratic Republic of the Congo (DRC) declared an outbreak of Ebola, the situation has improved, but the outbreak continues.
Aug 22, 2019
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will provide $23 million for Merck to produce additional doses of its investigational Ebola vaccine over the next year as part of the international response to the outbreak in the Democratic…
Aug 13, 2019
Patients receiving either of two investigational treatments for Ebola in the Democratic Republic of the Congo had a greater chance of survival than those receiving two other treatments as part of the clinical trial.